3 Drug Stocks Poised for Gains After Cancer Conference

Drug and biotechnology stocks that offer a range of cancer therapies have come under the microscope this week after a five-day conference, put on by the European Society for Medical Oncology, concluded Tuesday. The Barcelona-based event provided an opportunity for leading companies in the space to present new findings as well as update patients and investors on the results of clinical trials.